| Phase III |
A controlled, open-label post-authorisation efficacy and safety study in imlifidase… |
Nephrology |
Yes |
| Phase III |
A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol… |
Pediatric Cardiology |
No |
| Phase III |
A multi-center, open-label, uncontrolled, single-arm, extension study to determine the… |
Neurology |
Yes |
| Phase III |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group… |
Neurology |
Yes |
| Phase II |
A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy and… |
Infectious |
No |
| Phase II |
A phase 2, 24-week, adaptive, open label, sequential cohort trial to evaluate the… |
Nephrology |
Yes |
| Phase II |
A phase 2, multicenter, open-label study to assess appropriate dosing and to evaluate… |
Pediatric Oncohematology |
Yes |
| Phase II |
A Phase 2, Open-Label, Single-Arm Study of Pamiparib (BGB-290) for the Treatment of… |
Unclassified |
No |
| Phase II |
A Phase 2 Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides… |
General Pediatrics and Specialties |
Yes |
| Phase II |
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-finding… |
Unclassified |
Yes |
| Phase II |
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate theSafety, Efficacy,… |
Nephrology |
Yes |
| Phase III |
A phase 2/3, randomized, open-label, parallel group, 2-arm, multicenter study… |
Internal Medicine |
Yes |
| Phase III |
A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability,… |
General Pediatrics and Specialties |
Yes |
| Phase III |
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445… |
Pneumology |
Yes |
| Phase III |
A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination… |
Pneumology |
Yes |
| Phase III |
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to… |
Infectious |
Yes |
| Phase III |
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate… |
Pneumology |
No |
| Phase III |
A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111)… |
General Pediatrics and Specialties |
Yes |
| Phase III |
A Phase 3 Study of the Efficacy and Safety of Lixivaptan in Participants with Autosomal… |
Nephrology |
No |
| Phase III |
A Phase 3b, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Elexacaftor/… |
Obstetrics |
Yes |
| Phase III |
A PHASE IIIb MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO… |
Neuroimmunology |
Yes |
| Phase III |
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy… |
Cardiology |
Yes |
| Phase III |
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the… |
Nephrology |
Yes |
| Phase II |
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358)… |
Rheumatology |
Yes |
